Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.

AstraZeneca (NASDAQ:AZN) used its presentation at the J.P. Morgan Healthcare Conference to highlight strong 2025 performance, ...

AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a ...

The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the ...

EsoBiotec SA, a biotechnology company specializing in in vivo cell therapies, has announced a definitive agreement to be acquired by AstraZeneca PLC (NYSE:AZN). The agreement represents a major step ...

AstraZeneca PLC ADR advanced stock charts by Barron's. View AZN historical stock data and compare to other stocks, and ...

AstraZeneca PLC AZN shares rallied 4.89% to £140.38 Tuesday, on what proved to be an all-around positive trading session for ...

The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the ...

We recently compiled a list of the 20 High Growth Mega Cap Stocks You Can Buy And Hold For Next 5 Years. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

AstraZeneca PLC AZN +2.41% shares advanced 2.41% to £143.46 Wednesday, on what proved to be an all-around positive trading ...